Hasil Pencarian - Mina Nikanjam
- Menampilkan 1 - 12 hasil dari 12
-
1
Of Mice, Not Men: When the Bench-to-Bedside Bridge Is Broken oleh Mina Nikanjam, Shumei Kato, Razelle Kurzrock
Diterbitkan 2022-11-01Dapatkan teks lengkap
Artikel -
2
Dosing immunotherapy combinations: Analysis of 3,526 patients for toxicity and response patterns oleh Mina Nikanjam, Harsh Patel, Razelle Kurzrock
Diterbitkan 2017-08-01Dapatkan teks lengkap
Artikel -
3
Liquid biopsy: current technology and clinical applications oleh Mina Nikanjam, Shumei Kato, Razelle Kurzrock
Diterbitkan 2022-09-01Dapatkan teks lengkap
Artikel -
4
-
5
Tumor mutational burden is not predictive of cytotoxic chemotherapy response oleh Mina Nikanjam, Paul Riviere, Aaron Goodman, Donald A. Barkauskas, Garrett Frampton, Razelle Kurzrock
Diterbitkan 2020-01-01Dapatkan teks lengkap
Artikel -
6
Efficacy and safety of anticancer drug combinations: a meta-analysis of randomized trials with a focus on immunotherapeutics and gene-targeted compounds oleh Denis L. Jardim, Débora De Melo Gagliato, Mina Nikanjam, Donald A. Barkauskas, Razelle Kurzrock
Diterbitkan 2020-01-01Dapatkan teks lengkap
Artikel -
7
Relationship between tumor mutational burden and maximum standardized uptake value in 2-[18F]FDG PET (positron emission tomography) scan in cancer patients oleh Amin Haghighat Jahromi, Donald A. Barkauskas, Matthew Zabel, Aaron M. Goodman, Garret Frampton, Mina Nikanjam, Carl K. Hoh, Razelle Kurzrock
Diterbitkan 2020-12-01Dapatkan teks lengkap
Artikel -
8
Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients oleh Lindsey M. Charo, Ramez N. Eskander, Ryosuke Okamura, Sandip P. Patel, Mina Nikanjam, Richard B. Lanman, David E. Piccioni, Shumei Kato, Michael T. McHale, Razelle Kurzrock
Diterbitkan 2021-01-01Dapatkan teks lengkap
Artikel -
9
Expression of TIM3/VISTA checkpoints and the CD68 macrophage-associated marker correlates with anti-PD1/PDL1 resistance: implications of immunogram heterogeneity oleh Shumei Kato, Ryosuke Okamura, Yuichi Kumaki, Sadakatsu Ikeda, Mina Nikanjam, Ramez Eskander, Aaron Goodman, Suzanna Lee, Sean T. Glenn, Devin Dressman, Antonios Papanicolau-Sengos, Felicia L. Lenzo, Carl Morrison, Razelle Kurzrock
Diterbitkan 2020-01-01Dapatkan teks lengkap
Artikel -
10
Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study oleh Jason K. Sicklick, Shumei Kato, Ryosuke Okamura, Hitendra Patel, Mina Nikanjam, Paul T. Fanta, Michael E. Hahn, Pradip De, Casey Williams, Jessica Guido, Benjamin M. Solomon, Rana R. McKay, Amy Krie, Sarah G. Boles, Jeffrey S. Ross, J. Jack Lee, Brian Leyland-Jones, Scott M. Lippman, Razelle Kurzrock
Diterbitkan 2021-10-01Dapatkan teks lengkap
Artikel -
11
ATR inhibition facilitates targeting of leukemia dependence on convergent nucleotide biosynthetic pathways oleh Thuc M. Le, Soumya Poddar, Joseph R. Capri, Evan R. Abt, Woosuk Kim, Liu Wei, Nhu T. Uong, Chloe M. Cheng, Daniel Braas, Mina Nikanjam, Peter Rix, Daria Merkurjev, Jesse Zaretsky, Harley I. Kornblum, Antoni Ribas, Harvey R. Herschman, Julian Whitelegge, Kym F. Faull, Timothy R. Donahue, Johannes Czernin, Caius G. Radu
Diterbitkan 2017-08-01Dapatkan teks lengkap
Artikel -
12
Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy oleh Shumei Kato, Ki Hwan Kim, Hyo Jeong Lim, Amelie Boichard, Mina Nikanjam, Elizabeth Weihe, Dennis J. Kuo, Ramez N. Eskander, Aaron Goodman, Natalie Galanina, Paul T. Fanta, Richard B. Schwab, Rebecca Shatsky, Steven C. Plaxe, Andrew Sharabi, Edward Stites, Jacob J. Adashek, Ryosuke Okamura, Suzanna Lee, Scott M. Lippman, Jason K. Sicklick, Razelle Kurzrock
Diterbitkan 2020-10-01Dapatkan teks lengkap
Artikel